Why is epidermal growth factor present in the gut lumen?

R J Playford, N A Wright

Department of Gastroenterology, Leicester General Hospital.

The jury is still out on the role of luminal EGF in the normal gastrointestinal tract. Recent evidence, however, suggests that its major function is to act as a 'luminal surveillance' peptide, which is available to stimulate repair and that it is not of major importance in maintaining normal gut growth. Recombinant EGF administered via the gut lumen could still prove a valuable tool for the treatment of gastrointestinal ulceration. Perhaps the old term for EGF, 'epidermal healing factor' or EHF, was more appropriate after all!

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Cheung, Q. C., Yuan, Z., Dyce, P. W, Wu, D., DeLange, K., Li, J. (2009). Generation of epidermal growth factor-expressing Lactococcus lactis and its enhancement on intestinal development and growth of early-weaned mice. Am. J. Clin. Nutr. 89: 871-879 [Abstract] [Full Text]  
• Lamb-Rosteski, J. M., Kalischuk, L. D., Inglis, G. D., Buret, A. G. (2008). Epidermal Growth Factor Inhibits Campylobacter jejuni-Induced Claudin-4 Disruption, Loss of Epithelial Barrier Function, and Escherichia coli Translocation. Infect. Immun. 76: 3390-3398 [Abstract] [Full Text]  
• Hare, K. J., Hartmann, B., Kissow, H., Holst, J. J., Poulsen, S. S. (2007). The Intestinotrophic Peptide, GLP-2, Counteracts Intestinal Atrophy in Mice Induced by the Epidermal Growth Factor Receptor Inhibitor, Gefitinib. Clin. Cancer Res. 13: 5170-5175 [Abstract] [Full Text]  
• Elliott, S. N., Wallace, J. L., McKnight, W., Gall, D. G., Hardin, J. A., Olson, M., Buret, A. (2000). Bacterial colonization and healing of gastric ulcers: the effects of epidermal growth factor. Am. J. Physiol. Gastrointest. Liver Physiol. 278: G105-G112 [Abstract] [Full Text]  
• Powell, D. W., Mifflin, R. C., Valentich, J. D., Crowe, S. E., Saada, J. I., West, A. B. (1999). Myofibroblasts. II. Intestinal subepithelial myofibroblasts. Am. J. Physiol. Cell Physiol. 277: C183-C201 [Abstract] [Full Text]  
• Powell, D. W., Mifflin, R. C., Valentich, J. D., Crowe, S. E., Saada, J. I., West, A. B. (1999). Myofibroblasts. I. Paracrine cells important in health and disease. Am. J. Physiol. Cell Physiol. 277: C1-C19 [Abstract] [Full Text]  
• Beltinger, J., Hawkey, C. J., Stack, W. A. (1999). TGF-alpha reduces bradykinin-stimulated ion transport and prostaglandin release in human colonic epithelial cells. Am. J. Physiol. Cell Physiol. 276: C848-C855 [Abstract] [Full Text]  
• Furukawa, O., Matsui, H., Suzuki, N., Okabe, S. (1999). Epidermal Growth Factor Protects Rat Epithelial Cells Against Acid-Induced Damage Through the Activation of Na+/H+ Exchangers. J. Pharmacol. Exp. Ther. 288: 620-626 [Abstract] [Full Text]  
• Luetteke, N., Qiu, T., Fenton, S., Troyer, K., Riedel, R., Chang, A, Lee, D. (1999). Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development. Development 126: 2739-2750 [Abstract]  
• Buret, A., Olson, M. E., Gall, D. G., Hardin, J. A. (1998). Effects of Orally Administered Epidermal Growth Factor on Enteropathogenic Escherichia coli Infection in Rabbits. Infect. Immun. 66: 4917-4923 [Abstract] [Full Text]  
• Dvorak, B., Halpern, M. D., Holubec, H., Williams, C. S., McWilliam, D. L., Dominguez, J. A., Stepankova, R., Payne, C. M., McCuskey, R. S. (2002). Epidermal growth factor reduces the development of necrotizing enterocolitis in a neonatal rat model. Am. J. Physiol. Gastrointest. Liver Physiol. 282: G156-G164 [Abstract] [Full Text]